# Liver Adiposity Effects on Pediatric Statin

> **NCT04903223** · PHASE1 · RECRUITING · sponsor: **Children's Mercy Hospital Kansas City** · enrollment: 50 (estimated)

## Conditions studied

- Cholesterol; Lipidosis

## Interventions

- **DRUG:** Rosuvastatin 10mg

## Key facts

- **NCT ID:** NCT04903223
- **Lead sponsor:** Children's Mercy Hospital Kansas City
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04903223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04903223, "Liver Adiposity Effects on Pediatric Statin". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04903223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*